OOIR: Observatory of International Research

Papers

(The median citation count of Experimental Hematology is 0. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)

Article	Citations
RNA methylation: where to from here for hematologic malignancies?	42
3131 – DISPARITIES IN IMMUNOSUPPRESSIVE PROFILES BETWEEN RELAPSED AML WITH OR WITHOUT ALLO-HCT	33
3008 – INTEGRATED IN SILICO AND IN VITRO APPROACHES MATCH DEVELOPMENTAL CELL-OF-ORIGIN TO THERAPEUTIC VULNERABILITIES IN INFANT LEUKEMIA	31
3127 – INDUCTION OF ONTOGENY-SPECIFIC CD24+ PRELEUKEMIC STEM CELLS IN A KMT2A::AFF1 MURINE MODEL	29
3055 – THE 3′ DISTAL ENHANCER REGION OF THE CEBPB GENE IS ESSENTIAL FOR MONOCYTE DEVELOPMENT	27
3133 – UNCOVERING DISTINCT METABOLIC PROPERTIES OF RELAPSE AND RELAPSE-FATED CLONES IN B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA	25
Distinct transcriptional changes in hematopoietic progenitor subsets on LPS-induced emergency granulopoiesis	25
3116 – MITOCHONDRIAL FUSION AGONISTS IMPROVE EXPANDED CORD BLOOD HEMATOPOIETIC STEM AND PROGENITOR CELLS FUNCTION IN VIVO	23
2019 – DURING AGEING, THE HEMATOPOIETIC STEM CELL GENOME IS PROTECTED BY DORMANCY, NOT APOPTOSIS.	23
3016 – MYCT1 CONTROLS HUMAN HEMATOPOIETIC STEM CELL FUNCTION BY MODERATING ENDOCYTOSIS AND ENVIRONMENTAL SENSING	21
3059 – UNRAVELLING HUMAN HEMATOPOIETIC PROGENITOR CELL DIVERSITY THROUGH ASSOCIATION WITH INTRINSIC REGULATORY FACTORS	19
Corrigendum to ’ 5-Aza-dC promotes T-cell acute lymphoblastic leukemia cell invasion via downregulation of DNMT1 and upregulation of MMP-2 and MMP-9’ [Volume 114, October 2022, Pages 43-53.e2]	19
RNAi Screen Identifies MTA1 as an Epigenetic Modifier of Differentiation Commitment in Human HSPCs	19
Corrigendum to A novel lymphoid progenitor cell population (LSKlow) is restricted by p18INK4c Experimental Hematology Volume 44 Issue 9 (2016), 874-885.e5	17
3033 – DIFFERENTIAL RESPONSES AND RECOVERY DYNAMICS OF HAEMATOPOIETIC POPULATIONS FOLLOWING PLASMODIUM CHABAUDI INFECTION	17
Neutrophil death-more than meets the eye	17
1022 – ADVANCES IN CELLULAR BARCODING: EXPLORING HEMATOPOIETIC STEM CELLS AGEING AND METABOLIC FUNCTIONS IN LINEAGE SPECIFICATION	16
1007 – GENOMIC REPETITIVE ELEMENTS SIGNAL SURFACE B2M TO BLOCK PHAGOCYTOSIS OF HSCS	16
IFC Editorial Board	15
3194 – CLONAL HEMATOPOIESIS-ASSOCIATED DNMT3A MUTATIONS CAUSE INCREASED T CELL ACTIVATION AND DECREASED LEUKEMIC TUMOR BURDEN	15
3060 – BONE MARROW MESENCHYMAL STEM CELLS RELY ON VASCULAR CELL ADHESION MOLECULE-1 FOR SURVIVAL AND NICHE MAINTENANCE	14
1030 – CELLULAR AND MOLECULAR MECHANISMS OF HEMATOPOIETIC LINEAGE CHOICE	14
3215 – TWO NOVEL ENHANCERS OF CDKN1A ARE EPIGENETICALLY REGULATED BY THE CHROMATIN ASSEMBLY FACTOR 1 AND CEBPA IN ACUTE MYELOID LEUKEMIA	14
Notch1 activation and inhibition in T-cell acute lymphoblastic leukemia subtypes	13
3144 – GRX1 DEGLUTATHIONYLATES NF-κB P65 TO INCREASE LAG3 EXPRESSION IN T CELLS AND PROMOTE TUMOR GROWTH	13

CD20-Targeted Immunotherapies in B-Cell Malignancies: Mechanistic and Clinical Advances	13
3064 – ALKBH5 MODULATES HEMATOPOIETIC STEM AND PROGENITOR CELL ENERGY METABOLISM THROUGH M6A MODIFICATION-MEDIATED RNA STABILITY CONTROL	13
Dynamics of human hematopoietic stem and progenitor cell differentiation to the erythroid lineage	13
3129 – PREEMPTIVE TARGETING OF PRELEUKEMIC CELLS IN DOWN SYNDROME WITH PATHWAY-DIRECTED THERAPIES: A NOVEL APPROACH TO PREVENT MYELOID LEUKEMIA	12
3185 – A MACHINE LEARNING PIPELINE UNCOVERS LAG-3-MEDIATED IMMUNOREGULATION IN INFLAMMATORY HSCs	12
3085 – THERMAL PROTEOME IDENTIFIES KEY REGULATORS IN HEMATOPOIETIC STEM CELLS	12
3218 – LYL1 IS CRITICAL FOR ADULT HEMATOPOIETIC STEM CELL-DERIVED B- AND T-LYMPHOPOIESIS	12
2015 – MENIN ORCHESTRATES EXPRESSION OF THE MASTER PLASMA CELL TRANSCRIPTION FACTOR IRF4 AND IS AN ACTIONABLE TARGET IN MULTIPLE MYELOMA.	11
3089 – AN ITGB3 CYTOPLASMIC MUTATION CAUSES MACROTHROMBOCYTOPENIA VIA IMPAIRED αIIBβ3–RHOA SIGNALING	11
1006 – HEMATOPOIETIC STEM CELL ACTIVATION FOR BLOOD REGENERATION	11
3187 – MECOM PROMOTES LEUKEMIA PROGRESSION AND INHIBITS MAST CELL DIFFERENTIATION THROUGH FUNCTIONAL COMPETITION WITH GATA2	11
1005 – MAPPING THE DEVELOPMENTAL PATHWAYS TO HUMAN HEMATOPOIETIC AND LEUKEMIC STEM CELLS	11
3138 – LIMS1 REGULATES ACUTE MYELOID LEUKEMIA INITIATION THROUGH CELL ADHESION INTERACTIONS AND MIGRATION OF LEUKEMIC STEM CELLS	11
3004 – IN VITRO EXPANDED HEMATOPOIETIC STEM CELLS COMBINED WITH NON-GENOTOXIC CONDITIONING ENABLE EFFICIENT TRANSPLANTATION AND SUPPRESS MYELOID DISEASE	11
Ontogeny, dynamics, and characteristics of neutrophils during the perinatal period	10
Effect of peritransplant measurable residual disease clearance in patients with myelodysplastic neoplasm: a referral center experience	10
Gene regulatory complexes: their role and regulation across normal and malignant hematopoiesis	10
3110 – EGFL7 IS IMPORTANT FOR CELL CYCLE REGULATION AND PROLIFERATION OF HSCS	10
Cover 2: Editorial Board	10
3220 – THE BONE MARROW EXTRACELLULAR MATRIX REMODELLING DURING ACUTE MYELOID LEUKAEMIA	10
JQ-1/bortezomib combination strongly impairs MM and PEL survival by inhibiting c-Myc and mTOR despite the activation of prosurvival mechanisms	9
3054 – MESENCHYMAL STEM CELLS REVERSIBLY DE-DIFFERENTIATE MYOFIBROBLASTS TO FIBROBLAST-LIKE CELLS BY INHIBITING THE TGF-Β-SMAD2/3 PATHWAY	9
2024 – UNDERSTANDING HOW THE TISSUE MICROENVIRONMENT DIRECTS CELL FATE IN HAEMATOPOIETIC STEM AND PROGENITOR CELLS	9
3124 – ANALYSIS OF TRANSCRIPTOMIC AND EPITRANSCRIPTOMIC EFFECTS OF THE ACUTE MEGAKARYOBLASTIC LEUKEMIA FUSION PROTEIN RBM15-MKL1	9
3069 – EXPANSION OF A NOVEL LEUKEMIA STEM CELL-SUPPORTING CD55+ FIBROBLAST POPULATION IN THE PRELEUKEMIC BONE MARROW	9
3141 – METABOLIC PROFILING OF HEMATOPOIETIC STEM CELLS (HSCS) FOLLOWING ACUTE INFLAMMATION	9
3174 – DOWNREGULATION OF MITOCHONDRIAL COMPLEX II IN MYELODYSPLASTIC SYNDROMES	9
2016 – CD32 ALLOWS CAPTURING BLOOD CELLS EMERGENCE IN SLOW MOTION DURING HUMAN EMBRYONIC DEVELOPMENT	9
3055 – MULTI-OMICS REVEALS AZACITIDINE PARTIALLY RESTORES THE HEMATOPOIESIS-SUPPORTIVE FUNCTIONS IN MESENCHYMAL STROMAL CELLS FROM PATIENTS WITH CHRONIC MYELOMONOCYTIC LEUKEMIA	8
Building bones for blood and beyond: the growing field of bone marrow niche model development	8
3192 – DEFINING THE MECHANISMS OF BST2 IN INFLAMMATION-DEPENDENT HEMATOPOIETIC STEM CELL ACTIVATION	8
2004 – INFLAMMATORY FACTORS ORCHESTRATE THE BIRTH OF HSPCS THROUGH THEIR OSCILLATORY SIGNALING DYNAMICS	8
3131 – CROSS-SPECIES TRANSCRIPTOMICS REVEALS BIFURCATION POINT DURING THE ARTERIAL-TO-HEMOGENIC TRANSITION	8
Downregulation of SATB1 by miRNAs reduces megakaryocyte/erythroid progenitor expansion in preclinical models of Diamond–Blackfan anemia	8
Endogenous small molecule effectors in GATA transcription factor mechanisms governing biological and pathological processes	7
Prognostic significance of myeloid-derived suppressor cells and systemic inflammation in newly diagnosed diffuse large B cell lymphoma treated with chemoimmunotherapy	7
ZC3H13 facilitates the progression of acute myeloid leukemia through m6A-FOXP1-mediated metabolic reprogramming	7
3168 – TARGETING JAK1 SIGNALING FOR MOLECULAR PREVENTION IN CLONAL HEMATOPOIESIS	7
3073 – EARLY IDENTIFICATION OF STEROID-REFRACTORY GRAFT-VERSUS-HOST DISEASE BY F-DEX ASSAY AND MURINE MODELS	7
Reproducibility of low-level residual myeloma immunoglobulin detection using ultra-deep sequencing	7
Splicing the Difference: Harnessing the Complexity of the Transcriptome in Hematopoiesis	7
2008 – SELF-RENEWAL OF LATE-STAGE ERYTHROID PROGENITORS	7
3043 – FETAL EMERGENCY MYELOPOIESIS IS RESTRICTED BY MATERNAL INFLAMMATION.	7
3011 – UNIQUE ROLES OF KMT2A FAMILY MEMBERS IN HEMATOPOIESIS AND LEUKEMIA	7
A new era of functional experimentation in human hematopoiesis and leukemia research	7
Current landscape of mRNA therapeutics for acute myeloid leukemia	7
3057 – MULTIOME ANALYSIS IDENTIFIES HSC SUBSETS WITH THYMIC REGENERATIVE CAPACITY	7
3097 – THE LONG NONCODING RNA ELDR AS A NEW THERAPEUTIC TOOL AGAINST HUMAN ACUTE MYELOID LEUKEMIA (AML)	7
3108 – PHOSPHORYLATION OF RUNX1 PROMOTES MEGAKARYOCYTIC FATE IN MEGAKARYOCYTE-ERYTHROID PROGENITOR FATE SPECIFICATION	7
3027 – CASEIN KINASE II ALPHA (CK2A) DELETION AFFECTS MYELOID HEMATOPOIESIS IN CONDITIONAL KNOCKOUT MOUSE MODEL	6

Ubiquitin E3 ligase FBXO21 regulates cytokine-mediated signaling pathways, but is dispensable for steady-state hematopoiesis	6
3042 – PRECISE INTRODUCTION OF SRSF2 P95H RECAPITULATES DISEASE PHENOTYPES AND GIVES INSIGHT INTO THE CELLULAR MECHANISM OF ACTION	6
3110 – EX VIVO CRISPR-BASED SICKLE CELL MODELING	6
Preconditioning intervention prior to allogeneic hematopoietic stem cell transplantation in patients with high-risk acute myeloid leukemia	6
3190 – ACCOUNTING FOR BIOLOGICAL VARIATION IN SCRNA-SEQ QUALITY CONTROL METRICS RETAINS DISTINCT NICHE AND HEMATOPOIETIC CELL TYPES	6
3187 – INVESTIGATION OF THE THERAPEUTIC EFFECT OF A NOVEL SMALL MOLECULE INHIBITING YBX1 IN MYELOID MALIGNANCIES	6
3193 – THE FUNCTIONAL ROLE OF NUCLEAR PROTEIN 1 (NUPR1) IN AGE-RELATED HEMATOPOIETIC STEM CELL FATE PRIMING	6
Mtg16 NHR1 mutations cause defects in lymphopoiesis and the response to anemia	5
3128 – IDENTIFICATION AND CHARACTERIZATION OF CD96+CD70+ LEUKEMIC STEM CELLS AND NICHE-MEDIATED RESISTANCE IN CBFA2T3-GLIS2 AMKL	5
3076 – EARLY MYELOID COMMITMENT OF HSCS: MAFB AS A MASTER REGULATOR?	5
Glucose-6-phosphate dehydrogenase is dispensable for human erythroid cell differentiation in vitro	5
3180 – SRSF2 P95H AND NF1 DEFICIENCY SYNERGIZE TO PROMOTE MYELOID-BIASED CLONAL HEMATOPOIESIS FROM HEMATOPOIETIC STEM CELLS VIA JAK-STAT ACTIVATION IN MICE	5
3163 – ANTI-CD69 MONOCLONAL ANTIBODY AVENUE DISEASE PROGRESSION IN A MOUSE MODEL OF CHRONIC MYELOMONOCYTIC LEUKEMIA WITH NRASG12D MUTATION	5
Development and aging of resident endothelial stem cells in pre-existing blood vessels	5
Immune control in acute myeloid leukemia	5
Inflammation-related mRNA expression in patients with multiple myeloma undergoing hematopoietic stem cell mobilization	5
Avatrombopag is effective in patients with chemoradiotherapy-induced aplastic anemia: a single-center, retrospective study	5
1002 – BONE MARROW FAILURE AND CLONAL EVOLUTION	5
3097 – CLONAL COMPETITION, FITNESS, AND MUTATION TIMING DRIVE ADVERSE OUTCOMES IN CLONAL HEMATOPOIESIS	5
2006 – RAS MUTATIONS TRANSFORM GRANULOCYTE-MONOCYTE PROGENITORS INTO INFLAMMATORY LEUKEMIA STEM CELLS IN ACUTE MYELOID LEUKEMIA	5
1024 – A GENETIC LABELING STRATEGY FOR COMPETITIVE XENOTRANSPLANTATION OF HUMAN HSCS	5
3052 – PLZF LOSS-OF-FUNCTION ALTERS THE HEMATOPOIETIC STEM CELL COMPARTMENT IN AN AGE-DEPENDENT MANNER	5
Effect of Clonal Hematopoiesis on Cardiovascular Disease in People Living with HIV	5
Generation of functionally distinct hemogenic endothelial cell populations from pluripotent stem cells	5
In Memoriam: Prof. Vittorio Rizzoli, The visionary who built experimental hematology in Italy	5
Analysis of risk factors for early death of lymphocyte subsets in adult patients with secondary hemophagocytic lymphohistiocytosis	5
C-COUNT: a convolutional neural network–based tool for automated scoring of erythroid colonies	5
3082 – SECRETOMIC CHARACTERIZATION OF REVITALIZED BONE MARROW STROMAL CELLS IDENTIFIES SEMAPHORIN 3A AS A NICHE FACTOR THAT REGULATES HSC QUIESCENCE	5
3021 – EX VIVO EXPANSION OF HEMATOPOIETIC PROGENITOR CELLS DERIVED FROM INDUCED PLURIPOTENT STEM CELLS	5
3151 – PUTTING THE STING BACK INTO THERAPY FOR P53 MUTANT BLOOD CANCERS	5
Inhibition of PAK1 generates an ameliorative effect on MPLW515L mouse model of myeloproliferative neoplasms by regulating the differentiation and survival of megakaryocytes	5
1024 – NICOTINAMIDE RIBOSIDE ENHANCES AMINO ACID CATABOLISM TO REJUVENATE OLD HEMATOPOIETIC STEM CELLS BY RESTORING THEIR METABOLISM AND PROTEOSTASIS	5
TET2 loss enhances early response to inflammation in primitive and committed myeloid cells	5
1032 – STEM CELLS IN HUMAN AML	4
3012 – DEEPLY QUIESCENT HEMATOPOIETIC STEM CELLS MAINTAIN FUNCTION BY GPRASP2-MEDIATED CELL-SURFACE RECEPTOR DEGRADATION	4
3018 – DETERMINING THE VARIATIONS OF THE NEUTROPHIL TO LYMPHOCYTE RATIO (NLR) IN CANCER PATIENTS - A PROSPECTIVE STUDY	4
2023 – INTRA- AND EXTRACELLULAR PROTEOME DYNAMICS DURING NORMAL AND MALIGNANT HEMATOPOIETIC STEM CELL EXPANSION	4
2004 – A SINGLE-CELL PROTEOMICS BY MASS SPECTROMETRY BASED MAP OF THE HUMAN CD34+ HEMATOPOIETIC STEM AND PROGENITOR CELL COMPARTMENT	4
3029 – ISOFORM SPECIFIC ROLES FOR CD97 IN ACUTE MYELOID LEUKEMIA	4
Functional and molecular profiling of hematopoietic stem cells during regeneration	4
3213 – DISSECTING THE BLOOD ECOSYSTEM IN SARS-COV-2 OMICRON PATIENTS	4
3173 – HAPLODEFICIENCY OF THE MTAP/CDKN2 LOCUS DRIVES IMMUNOMETABOLIC DYSREGULATION AND STROMAL CELL ALTERATIONS LEADING TO MYELODYSPLASTIC SYNDROMES-LIKE DISEASE	4
2011 – SUBCLONAL MUTATIONS ALTER CORE SIGNALLING NODES AND DRUG RESPONSES IN PAEDIATRIC ACUTE LYMPHOBLASTIC LEUKAEMIA	4
Effects of ruxolitinib on murine regulatory T cells are immune-context dependent	4
1016 – FINE-TUNING TPO-MPL ACTIVITY TO CONTROL HEMATOPOIESIS	4
3076 – CHARACTERIZATION OF THE ROLE OF EIF4A IN THE RESISTANCE OF ACUTE MYELOID LEUKEMIA TO CHEMOTHERAPY AND TARGETED THERAPIES	4
3044 – IDENTIFICATION OF SURFACE MARKERS OF MALIGNANT CELL STATES IN ACUTE MYELOID LEUKEMIA USING EXPLAINABLE MACHINE LEARNING	4
3109 – IDENTIFICATION OF B LINEAGE COMMITMENT MARKERS FOR GENE EXPRESSION-BASED RISK STRATIFICATION OF INFANT KMT2A::AFF1 ACUTE LYMPHOBLASTIC LEUKEMIA	4
3122 – CUX1 LEVELS CONTROL HEMATOPOIETIC STEM CELL FATE AND PLASTICITY	4
Characterization of Human Engraftment and Hemophagocytic Lymphohistiocytosis in NSG-SGM3 Neonate Mice Engrafted with Purified CD34+ Hematopoietic Stem Cells	4
3003 – MASS SPECTROMETRY-BASED PROFILING OF BONE MARROW NICHE SECRETOME REMODELING IN AGING AND TET2-MUTANT CLONAL HEMATOPOIESIS	4
3086 – THE ROLE OF DEVELOPMENTAL WNT SIGNALING IN ABERRANT ADULT HEMATOPOIESIS	4
3198 – IGH TRANSLOCATIONS IN CHINESE PATIENTS WITH CHRONIC LYMPHOCYTICLEUKEMIA: CLINICOPATHOLOGIC CHARACTERISTICS AND GENETIC PROFILE	4
1004 – REGULATION OF THE HEMATOPOIETIC STEM CELL POOL BY C-KIT-ASSOCIATED TROGOCYTOSIS	4
3221 – KLF4/MLL3 CAMPASS COMPLEX TRANSCRIPT REGULATING NRBP2 TO ELIMINATE AML CELLS	4
1008 – UNIFIED SINGLE-CELL METHODS SORT DIVERGENT FATES THROUGH GENE REGULATION	4
Complementary and countervailing actions of Jak2 and Ikk2 in hematopoiesis in mice	4
3136 – RAMAN SPECTROSCOPY IMAGING TO TRACK ACTIVITY OF IMMUNE CELLS.	4
3120 – INVESTIGATING THE ROLE OF GPR56 IN ACUTE MYELOID LEUKAEMIA USING A TET-ON MODEL OF AN ACTIVATED GPR56 RECEPTOR IN HUMAN IPSC-DERIVED HAEMATOPOIETIC CELLS	4
TAZ downregulated ANXA1 expression to modulate myeloma cell interactions with bone marrow mesenchymal stromal cells	4
3119 – IDENTIFICATION OF CULTURE CONDITIONS THAT SUSTAIN THE IN VIVO REGENERATIVE PROPERTIES OF A NEW SUBSET OF HUMAN FETAL LIVER HEMATOPOIETIC STEM CELLS	4
3178 – FANCONI ANEMIA PROTEIN FANCD2 REGULATES FETAL LIVER HEMATOPOIETIC STEM CELL EXPANSION IN A CELL-INTRINSIC AND EXTRINSIC MANNER	3
3023 – CHARACTERIZATION OF THE ONCOGENIC ACTIVITY OF TLX1 AND TLX3 TRANSCRIPTION COMPLEXES IN T-ALL	3
3075 – DNMT3A LIMITS MYELOID SIGNALING RESPONSES IN T-CELL PROGENITORS DURING NORMAL AND LEUKEMIC DEVELOPMENT	3
3089 – ERK INHIBITORS SUPPRESS THE GROWTH OF LEUKEMIA CELLS	3
3001 – PCYT1A IS A METABOLIC VULNERABILITY IN MONOCYTIC ACUTE MYELOID LEUKEMIA	3
3018 – THE BILE ACID RECEPTOR TGR5 REGULATES THE COMPOSITION AND HEMATOPOIETIC SUPPORT CAPACITY OF THE BONE MARROW MICROENVIRONMENT	3
2012 – DENDRITIC CELLS IN DEVELOPING AND ADULT ZEBRAFISH ARISE FROM DIFFERENT ORIGINS AND DISPLAY DISTINCT FLT3 DEPENDENCIES	3
2023 – CELLULAR BARCODING OF THE LEUKEMIC NICHE REVEALS AN APELIN-MEDIATED CLONAL EXPANSION OF NICHE ENDOTHELIAL AND MESENCHYMAL STROMAL CELLS	3
3151 – THE ALTERNATIVE NUCLEOSOME REMODELING FACTOR COMPLEX SUSTAINS ACUTE MYELOID LEUKEMIA BY REGULATING THE ACCESSIBILITY OF INSULATOR REGIONS	3
Sustained MYC overexpression drives myeloid differentiation block and acquisition of leukemic phenotypes	3
Presence of mutant p53 increases stem cell frequency and is associated with reduced binding to classic TP53 binding sites in cell lines and primary AMLs	3
Highlighting the contributions of Professor T. Ray Bradley to ISEH and the field of Experimental Hematology	3
3246 – DEVELOPMENTAL AND FUNCTIONAL ANALYSIS OF MONOCYTES AND MACROPHAGES IN ZEBRAFISH DURING HEART REGENERATION	3
3068 – CRISPR SCREENING IN PRIMARY HUMAN CD34+ HEMATOPOIETIC STEM AND PROGENITOR CELLS IDENTIFIES THE RNA HELICASE DDX6 AS A NOVEL HSC REGULATOR	3
1005 – SWITCHING GENES ON AND OFF DURING HAEMATOPOIESIS	3
3171 – GLYCOLYSIS DRIVES IL-6 PRODUCTION BY BONE MARROW STROMAL CELLS DURING ACUTE INFLAMMATION	3
3048 – DISSECTING THE HETEROGENEITY OF EX VIVO EXPANDED HEMATOPOIETIC STEM AND PROGENITOR CELLS WITH MICRORNAS	3
Cover 2: Editorial Board	3
IFC Editorial Board	3

1007 – MAXIMIZING CELL DEATH IN LEUKEMIAS: BCL-2 AND BEYOND	3
Cell-extrinsic factors contribute toward myeloid-biased expansion in Tet2-mutant clonal hematopoiesis	3
AKT2 inhibition accelerates the acquisition of phagocytic ability in induced pluripotent stem cell–derived neutrophils	3
3201 – HEMATOPOIETIC STEM CELL-DERIVED CAR-IMMUNE SYSTEM FOR TUMOR IMMUNOTHERAPY	3
3068 – N-MYC EXPRESSION IS NEGATIVELY CORRELATED WITH SELF-RENEWAL POTENTIAL IN HSCS	3
2024 – A STEP-WISE AND DETERMINISTIC LEUKEMIA MOUSE MODEL REMINISCENT OF JMML WITH ENDOGENOUS ACQUISITION OF PATIENT-RELEVANT RTK–RAS MUTATIONS	3
3177 – CLONAL HEMATOPOIESIS PROMOTES HEART FAILURE WITH PRESERVED EJECTION FRACTION	3
1018 – MALPS: A MASTER REGULATOR OF BONE MARROW MICROENVIRONMENT	3
3036 – AUTOPHAGY REGULATES THE MATURATION OF HEMATOPOIETIC PRECURSORS IN THE EMBRYO	3
3027 – IDENTIFYING PIONEER FACTORS DURING HEMATOPOIETIC STEM CELL EMERGENCE	3
3177 – RUNX FACTORS LAUNCH T CELL AND INNATE LYMPHOID CELL PROGRAMS VIA DIRECT BINDING AND GENE NETWORK-BASED MECHANISMS	3
3056 – DNMT3A MUTATIONS UPREGULATE CELL ADHESION MOLECULES TO PROMOTE INVASIVENESS OF T-ALL CELLS	3
Trained immunity and epigenetic memory in long-term self-renewing hematopoietic cells	3
Assay optimization for the objective quantification of human multilineage colony-forming units	3
Fetal allotransplant recipients are resistant to graft-versus-host disease	3
3235 – HYPERDIPLOIDY IMPAIRS FETAL HSPC FITNESS AND DIFFERENTIATION ENABLING LONG-TERM PERSISTENCE OF RARE PRELEUKEMIC TRISOMIC CLONES IN BONE MARROW	2
A-to-I RNA editing and hematopoiesis	2
1029 – ETIOLOGY, PATHOGENESIS AND CELL-OF-ORIGIN OF MLL-REARRANGED INFANT/PEDIATRIC B-CELL ALL	2
3148 – EMP- AND HSC-DERIVED NEUTROPHILS DYNAMICALLY CONTRIBUTE TO THE DEVELOPING MOUSE HEMATOPOIETIC SYSTEM	2
Cohesin haploinsufficiency is tolerated in Cbfb::MYH11-driven murine acute myeloid leukemia	2
3179 – ID1 ABLATION RESCUES CLONAL HEMATOPOIESIS AND DELAYS DISEASE PROGRESSION IN TET2 NULL MICE	2
3064 – AN ACTIVATED GPR56 RECEPTOR ENHANCES SURVIVAL OF HUMAN IPSC-DERIVED HAEMATOPOIETIC STEM/PROGENITOR CELLS	2
1011 – MULTIPLEXING SPATIAL TRANSCRIPTOMICS, 4D IN SITU INTRAVITAL DATA AND 3D IMAGING TO DEFINE BONE MARROW MICROENVIRONMENTS IN INFLAMMATION AND BLOOD CANCER	2
2019 – ENDOTHELIAL CELL-DERIVED THROMBOSPONDIN-1 NEGATIVELY AFFECTS HEMATOPOIETIC FUNCTION DURING AGING	2
3139 – THE ROLE OF MYELOID CELLS HARBORING CLONAL HEMATOPOIESIS MUTATIONS IN ALZHEIMER'S DISEASE	2
1019 –	2
3099 – CYTOPLASMIC LOCALIZATION OF THE POLYCOMB PROTEIN CBX7 BLOCKS LEUKEMIC CELL GROWTH.	2
Differences in the mutational landscape of clonal hematopoiesis of indeterminate potential among races and between male and female patients with cancer	2
2009 – WORLD TRADE CENTER 9/11 DISASTER EXPOSURE IS ASSOCIATED WITH CLONAL HEMATOPOIESIS IN FIRST RESPONDERS AND IS CHARACTERIZED BY INNATE IMMUNE INFLAMMATION.	2
1022 – THE DEVELOPMENTAL ORIGINS OF BLOOD AND BLOOD CANCER	2
3111 – BCL11B ORCHESTRATES GENERATION OF LYMPHOID-PRIMED DEFINITIVE HEMATOPOIETIC PROGENITORS FROM HUMAN INDUCED PLURIPOTENT STEM CELLS	2
2022 – TRANSCRIPTION FACTOR REDISTRIBUTORS ACTUATE NON-CANONICAL GENE CIRCUITS TO DRIVE AML DIFFERENTIATION	2
3158 – VENETOCLAX AND PROTEASOME INHIBITORS SYNERGISTICALLY INDUCE APOPTOSIS IN ACUTE MYELOID LEUKEMIA	2
3145 – SINGLE-CELL RNA SEQUENCING REVEALS GATA3 REGULATES DIFFERENTIATION OF REGULATORY T CELLS IN AML	2
3095 – SEX-SPECIFIC DIFFERENCES IN PLATELET PARAMETERS AND THE UTILITY OF MEAN PLATELET VOLUME/ PLATELET COUNT RATIO IN DIAGNOSING IRON DEFICIENCY ANEMIA	2
3007 – T-CELL MEDIATED STEM-LIKE PLASTICITY OF GERMINAL CENTER B CELLS	2
3106 – PROTEOMICS AND GENOMICS STUDIES REVEALED A NEW ROLE FOR MLL PARTIAL TANDEM DUPLICATION (PTD) IN MYELODYSPLASTIC SYNDROME (MDS) AND ACUTE MYELOID LEUKEMIA (AML)	2
Transcriptional and functional consequences of Oncostatin M signaling on young Dnmt3a-mutant hematopoietic stem cells	2
3247 – A PROMISING PLANT ALKALOID PROVIDES NEUROPROTECTION AGAINST AΒ-INDUCED TOXICITY IN SH-SY5Y CELLS	2
Prognostic role of the ratio of natural killer cells to regulatory T cells in patients with multiple myeloma treated with lenalidomide and dexamethasone	2
Efficacy and safety of avatrombopag in combination with standard immunosuppressive therapy for severe aplastic anemia	2
3200 – RENIN-ANGIOTENSIN SYSTEM INHIBITORS SUPPRESS THE GROWTH OF LEUKEMIA CELLS	2
3150 – GATA2 DETERMINES HEMATOPOIETIC STEM/PROGENITOR CELL RESPONSES TO OPPORTUNISTIC FUNGAL INFECTION	2
Cover 2: Editorial Board	2
Novel techniques to quantitatively assess age-dependent alterations in biophysical properties of HSPCs and bone marrow niche	2
1012 – DEVELOPMENTAL PROGRAMMING OF TISSUE-RESIDENT MACROPHAGES	2
3047 – A NAD+ METABOLIC CHECKPOINT REGULATES HEMATOPOIETIC STEM CELL ACTIVATION AND AGING	2
Cover 2: Editorial Board	2
3202 – M. AVIUM INDUCES EPIGENETIC REPROGRAMMED HSPC-TRAINED IMMUNITY THAT ALTERS DOWNSTREAM MYELOID IMMUNE FUNCTION.	2
Honoring giants in hematopoietic stem and progenitor cell biology	1
From Gamma to X: Same destination but different journey ?	1
Harnessing the potential of gene-editing technology to overcome the current bottlenecks of CAR-T cell therapy in T-cell malignancies	1
Mechanistic insights into gene regulation driving normal and malignant hematopoietic development from embryonic and induced pluripotent stem cell differentiation.	1
2020 – PRECISE SINGLE-CELL TRANSCRIPTOMIC MAPPING OF NORMAL AND LEUKEMIC CELL STATES REVEALS UNCONVENTIONAL LINEAGE PRIMING IN ACUTE MYELOID LEUKEMIA	1
3175 – AN UNSUPERVISED INTEGRATION FRAMEWORK TO COMPREHENSIVELY CAPTURE HUMAN HEMATOPOIETIC STEM CELL VARIATION IDENTIFIES HALLMARK SIGNATURES WITH A LINK TO AGING	1
3062 – PLATELETS SEQUESTER EXTRACELLULAR DNA, CAPTURING TUMOR-DERIVED AND FREE FETAL DNA	1
3248 – LARGE-SCALE PRODUCTION OF TRANSFUSION-READY CULTURED RED BLOOD CELLS FROM INDUCED PLURIPOTENT STEM CELLS	1
3207 – INDUCTION OF IMMUNE TOLERANCE BY PLURIPOTENT STEM CELLS AND ITS MECHANISMS	1
3200 – DEVELOPMENTAL REGULATION OF ENDOTHELIAL-TO-HEMATOPOIETIC TRANSITION FROM INDUCED PLURIPOTENT STEM CELLS	1
3140 – A TÊTE-À-TÊTE ABOUT TRISOMY 21: ELUCIDATING HOW PREDISPOSITION TO HEMATOLOGIC MALIGNANCIES IMPACTS CLONAL HEMATOPOIESIS	1
2024 – SPATIAL TRANSCRIPTOMICS CHARACTERIZE DYNAMIC AND POLARIZED NICHE CELLS AND SIGNALS FOR EMBRYONIC HEMATOPOIESIS	1
3118 – CHAPERONE-MEDIATED AUTOPHAGY MAINTAINS LEUKEMIC STEM CELLS	1
3201 – MOLECULAR CHARACTERISTICS OF MALIGNANT HEMATOPOIETIC STEM CELLS IN ESSENTIAL THROMBOCYTHEMIA ACROSS DISTINCT DRIVER MUTATIONS	1
A xeno-free red blood cell differentiation formula models sickle cell disease from somatically sourced patient iPSCs	1
3043 – SEX-DEPENDENT NICHE RESPONSES MODULATE STEADY-STATE AND REGENERATIVE HEMATOPOIESIS	1
3002 – TRANSCRIPTION FACTOR PROFILING REVEALS THAT CEBPA PROMOTES RIBOSOMAL RNA SYNTHESIS IN MYELOID PROGENITORS	1
Lethal and sublethal effects of programmed cell death pathways on hematopoietic stem cells	1
IFC Editorial Board	1
D816V KIT mutation induces mitochondrial morphologic and functional changes through BNIP3 downregulation in human myeloid cell lines ROSA and TF-1	1
3086 – APOPTOTIC CELLS-DERIVED CD14(+) MICROPARTICLES PROMOTE THE PHAGOCYTIC ACTIVITY OF NEUTROPHILIC PRECURSOR CELLS IN THE PHAGOCYTOSIS OF APOPTOTIC CELLS	1
3009 – BLOOD-RESIDENT MACROPHAGES (BMΦ) SAFEGUARD BLOOD AND VESSEL INTEGRITY	1
2022 – ENDOGENOUS FORMALDEHYDE-INDUCED DNA DAMAGE DRIVES STOCHASTIC STEM CELL LOSS AND CLONAL HEMATOPOIESIS	1
3005 – DIFFERENTIATION, AGING, AND LEUKEMIA ALTER THE METABOLIC PROFILE OF HUMAN BONE MARROW HEMATOPOIETIC STEM AND PROGENITOR CELLS	1
FT-4202, a selective pyruvate kinase R activator for sickle cell disease	1
2001 – BLOOD FLOW TRIGGERS MTORC1-DEPENDENT MITOCHONDRIAL REMODELING REQUIRED FOR HEMATOPOIETIC STEM CELL FATE	1
3015 – COORDINATED REGULATION AT THE SYSTEMIC AND LOCAL LEVELS PLAYS A PIVOTAL ROLE IN DETERMINING HEMATOPOIETIC STEM CELL NUMBERS	1
2015 – STRUCTURAL AND FUNCTIONAL ANALYSIS OF BONE MARROW STROMAL NETWORKS DURING CHEMOTHERAPY	1
3038 – SCIMP PROMOTES TLR SIGNALING AND REGULATES FUNCTION IN HEMATOPOIETIC STEM CELLS	1
3062 – HIGH THROUGHPUT EPIGENOMIC PROFILING IN HEMATOPOIETIC STEM/PROGENITOR FATE COMMITMENT	1
The (intra-aortic) hematopoietic cluster cocktail: what is in the mix?	1
3221 – NFAT TRANSCRIPTION FACTORS ARE REQUIRED FOR DEFINITIVE HEMATOPOIESIS	1
Metabolic regulation of erythrocyte development and disorders	1
3033 – DEPLETION OF CXCL10 (IP-10) REDUCES THE RED CELL PHENOTYPE AND MODIFIES SECRETION OF SERUM CYTOKINES IN MOUSE MODELS OF MYELOPROLIFERATIVE NEOPLASMS.	1
3145 – WHAT IS THE FUNCTION OF THE EPO-EPOR AXIS IN MATURE XENOPUS ERYTHROCYTES?	1
3031 – DEFINING THE MESODERMAL ORIGINS OF THE HUMAN HEMATOPOIETIC PROGRAMS USING PLURIPOTENT STEM CELLS	1
3039 – TRAINING STRESS TOLERANCE IN HEMATOPOIETIC STEM CELLS PRESERVES LONG-TERM FUNCTION	1
3183 – PROGRESSIVE IMBALANCE BETWEEN CLU⁺ AND CLU− HSCs DRIVES FUNCTIONAL HEMATOPOIETIC AGING	1
3177 – BONE MARROW MACROPHAGE RESILIENCE IS ASSOCIATED WITH BONE MARROW RECOVERY AND HEMATOPOIESIS POSTCHEMOTHERAPY INJURY	1
3195 – FISH IN COMBINATION WITH RT-PCR AIDS IN THE CLASSIFICATION OF B-OTHER ALL BY IMPROVING THE IDENTIFICATION OF THE ZNF384 REARRANGEMENT	1
3104 – EARLY MOLECULAR STEPS IN HUMAN BONE MARROW STEM CELL DIFFERENTIATION TRAJECTORIES	1
IFC Editorial Board	1
3047 – ROLE OF EPIGENETIC DYSFUNCTION IN CHRONIC NEUTROPHILIC LEUKEMIA	1
3044 – CRISPR ACTIVATION SCREENS IDENTIFY CO-DRIVERS OF MALIGNANT HAEMATOPOIESIS IN A DNMT3A MUTANT BACKGROUND	1
Peposertib suppresses generation of FLT3-internal tandem duplication formed by contralateral double nicks	1
3143 – ACUTE HEMATOPOIETIC RESPONSE OF GRANULOCYTE COLONY-STIMULATING FACTOR EXPRESSION IN MEDAKA FISH	1